MedPath

Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner

Completed
Conditions
Amblyopia
Strabismus
Registration Number
NCT01832883
Lead Sponsor
Rebiscan, Inc.
Brief Summary

The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • Children aged 3-8 years
  • Signed Informed consent by parent or guardian
  • Meet all inclusion criteria.
Exclusion Criteria
  • Children with a history of developmental delay or cognitive deficit
  • Children unable to complete the GSE (including visual acuity testing)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Binocularity scoreDay 1
Secondary Outcome Measures
NameTimeMethod
Presence of amblyopia risk factorsDay 1

'Anisometropia'- (1.5 Diopters (D) or more difference in refractive error between the two eyes.

'hypermetropia' (≥3.5 D), 'myopia' (≥-4.0 D), 'astigmatism' (≥1.5 D). 'structural abnormalities' of the eye will not be excluded, but will be considered to have vision loss if visual acuity is 20/40 or worse.

Trial Locations

Locations (1)

Vanderbilt Eye Institute

🇺🇸

Nashville, Tennessee, United States

Vanderbilt Eye Institute
🇺🇸Nashville, Tennessee, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.